 "Marksans Pharma up 10% after falling 40% in one week")
Shares of Marksans Pharma were locked in 10% upper circuit at Rs 63 on the BSE after falling 40% in the past one week.
The pharmaceuticals firm today said it has responded to UK Medicines and Healthcare products Regulatory Agency (MHRA) observations on 16th December 2015.
In past five trading sessions, the stock tanked 40% from Rs 95 to Rs 57 till yesterday after the media report suggests that the company’s Goa plant get notification of deficiency in goods manufacturing practices (GMP) from UK MHRA.
“UK MHRA GMP inspection of the company’s Goa plant commenced on November 23 and ended on November 25. UK MHRA issued observation on December 2, 2015 and company acknowledged on the same date”, Marksans Pharma said on clarification on the report.
Till 03:02 p.m. a combined 11.9 million shares changed hands and there were pending buy orders 331,802 shares on the BSE and NSE.
The pharmaceuticals firm today said it has responded to UK Medicines and Healthcare products Regulatory Agency (MHRA) observations on 16th December 2015.
In past five trading sessions, the stock tanked 40% from Rs 95 to Rs 57 till yesterday after the media report suggests that the company’s Goa plant get notification of deficiency in goods manufacturing practices (GMP) from UK MHRA.
“UK MHRA GMP inspection of the company’s Goa plant commenced on November 23 and ended on November 25. UK MHRA issued observation on December 2, 2015 and company acknowledged on the same date”, Marksans Pharma said on clarification on the report.
Till 03:02 p.m. a combined 11.9 million shares changed hands and there were pending buy orders 331,802 shares on the BSE and NSE.